-
-
Virtual education and specialist understanding amidst the COVID-19 pandemic
-
26th Mar 2020
-
Posted in Courses & Conferences
- Amended course dates and webinars from the MS Academy
-
-
Raising the bar through leadership: MS Leaders Academy
-
19th Mar 2020
-
Posted in Courses & Conferences
- An update on the MS Leaders Academy
-
-
Restoring Hand Function In Spinal Cord Injury using Nerve Transfer Surgery
-
18th Mar 2020
-
Posted in Awards & Appointments
- WFNR award winning research project shows how hand function can be restored in people with spinal cord injury (SCI) using nerve transfer surgery
-
-
Fremanezumab – first anti-CGRP preventive therapy approved by NICE
-
12th Mar 2020
-
Posted in Industry News
- Positive Recommendation by NICE for first anti-CGRP migraine therapy: AJOVY®▼ (fremanezumab)
-
-
Preview: SMi’s 20th Annual Pain Therapeutics – ONLINE CONFERENCE
-
12th Mar 2020
-
Posted in
- Preview of SMi Pharma's Pain Therapeutics meeting
-
-
Data from Phase III Trial “SPI2” for Treatment of Progressive MS
-
11th Mar 2020
-
Posted in Industry News
- News from MedDay Pharma
-
-
£1.68m to fund research in intracranial hypertension for Birmingham researcher
-
10th Mar 2020
-
Posted in Industry News
- Professor Alexandra Sinclair, University of Birmingham awarded £1.68m to fund research into intracranial hypertension
-
-
Essex collaboration focuses on people living with neurological conditions
-
10th Mar 2020
-
Posted in Industry News
- Research news from The University of Essex
-
-
Topline results of Phase 1-2 CDNF trial
-
7th Mar 2020
-
Posted in Industry News
- Industry news from Herantis Pharma
-
-
Preview: The British Neurotoxin Network Meeting
-
3rd Mar 2020
-
Posted in Courses & Conferences
- British Neurotoxin Network meeting preview
